NFCR Writer David Perry, Author at NFCR

NFCR Writer David Perry

The NFCR & AFCR Symposium: A Meeting of the Minds

On October 27th, the biannual 2019 Scientific Symposium on Cancer Research and Global Collaboration brought together the brightest minds of the National Foundation for Cancer Research (NFCR) and the Asian Foundation for Cancer Research (AFCR). Held in Rockville, MD, the three-day gathering was a chance for scientists funded by both…...

Read more

Ricardo Garcia: The Power of Repurposing

When volasertib was discontinued after an unsatisfactory Phase III clinical trial as an anti-leukemia drug, it did not die a quick death, or die at all. Like Viagra and thalidomide before it, volasertib was “repurposed;” if the original vision for the compound fails, it is simply a matter of finding…...

Read more

Wei Zhang: The Art of Precision

“The essence of precision medicine, in particular precision oncology, is to make cancer management more precise based on genomic mapping and molecular characterization of the unique tumors for each patient,” says Dr. Wei Zhang. “The cancer management that needs to be precision include diagnosis, prognosis, treatment plan, treatment monitoring, and…...

Read more